All-in-One ‘Polypill’ for Heart Patients

TUESDAY, Aug 30, 2022

In a discovering that proves comfort is vital with regards to sticking to a medicine routine, new analysis exhibits that combining three heart drugs into one “polypill” slashes the danger of dying from a second heart attack by 33%.

“The outcomes of the SECURE research present that for the primary time that the polypill, which incorporates aspirin, ramipril [an ACE inhibitor], and atorvastatin [Lipitor], achieves clinically related reductions within the recurrent cardiovascular occasions amongst individuals who have recovered from a earlier heart attack due to higher adherence to this simplified method with a easy polypill,” mentioned lead researcher Dr. Valentin Fuster. He is director of Mount Sinai Heart and physician-in-chief of Mount Sinai Hospital in New York City.

After a coronary heart assault, sufferers are sometimes prescribed three completely different drugs: an antiplatelet agent (like aspirin); ramipril or one other blood pressure drug; and a cholesterol-lowering drug, akin to a statin. Unfortunately, lower than 50% of sufferers take their drugs as prescribed, the researchers famous.

“Although most sufferers initially adhere to therapy after an acute occasion akin to an infarction [tissue death], adherence drops off after the primary few months. Our aim was to have an effect proper from the beginning, and many of the sufferers within the research started taking a easy polypill within the first week after having a coronary heart assault,” Fuster mentioned.

For the research, his crew randomly assigned almost 2,500 women and men who had a coronary heart assault to the brand new drug (Trinomia) or normal remedy. The common age of the members was 76.

Over three years of follow-up, the researchers discovered that these taking Trinomia had a 24% decrease threat total of a coronary heart assault, stroke, dying from cardiovascular disease or the necessity to have a process to open blocked coronary arteries than sufferers receiving normal care.

Even extra spectacular, Trinomia reduce the danger of dying from cardiovascular disease by 33%, the researchers famous. Patients taking Trinomia have been additionally extra more likely to adhere to their treatment routine than these taking three tablets.

“The SECURE research findings recommend that the polypill might change into an integral ingredient of methods to stop recurrent cardiovascular occasions in sufferers who’ve had a coronary heart assault,” Fuster mentioned in a hospital information launch. “By simplifying therapy and enhancing adherence, this method has the potential to cut back the danger of recurrent heart problems and dying on a world scale.”

The polypill used within the research has not been accredited by the U.S. Food and Drug Administration, The New York Times reported, however Fuster mentioned the placing outcomes can be submitted to the company shortly in an effort to get approval.

The findings have been introduced Friday on the European Society of Cardiology Congress in Barcelona, and printed concurrently within the New England Journal of Medicine.

“Combination pills are easier for the physician and for the patient, and the data are pretty clear — it translates into a benefit,” Dr. Thomas Wang, chair of the division of inner drugs at UT Southwestern Medical Center, who wrote an editorial accompanying the research, advised the Times. “It’s easier to take one pill versus multiple pills, and it’s easier to take them once a day than multiple times a day.”

More data

For extra on coronary heart assault, head to the American Heart Association.

SOURCES: Mount Sinai Hospital, information launch, Aug. 26, 2022; The New York Times

By Steven Reinberg HealthDay Reporter

Copyright © 2022 HealthDay. All rights reserved.

Heart Illustration
Browse through our medical image collection to see illustrations of human anatomy and physiology
See Images